92:@0.092505:0.957873:0.109687:0.957873:0.109687:0.938882:0.092505:0.938882:0.008591:0.008591
4:@0.038824:0.373065:0.060302:0.373065:0.060302:0.325587:0.038824:0.325587:0.021478
CHAPTER 4:@0.117647:0.067223:0.189946:0.067223:0.189946:0.047144:0.117647:0.047144:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.007844
Introduction:@0.117647:0.126494:0.256049:0.126494:0.256049:0.098384:0.117647:0.098384:0.006217:0.013626:0.010343:0.012928:0.013132:0.013103:0.013015:0.012722:0.010343:0.006217:0.013132:0.013626
Structural genomic variations (SVs) form a major class of somatic genetic variation in :@0.117647:0.168344:0.857141:0.168344:0.857141:0.147971:0.117647:0.147971:0.009793:0.006437:0.007967:0.011345:0.009108:0.006163:0.011413:0.007898:0.009405:0.005250:0.005798:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.005798:0.009838:0.009085:0.007807:0.005798:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.005798:0.006939:0.010112:0.015089:0.007670:0.006939:0.005798:0.006026:0.010843:0.007807:0.017645:0.005798:0.009291:0.005798:0.017577:0.008811:0.005341:0.010843:0.007807:0.005798:0.008765:0.005433:0.009291:0.007533:0.007670:0.005798:0.010843:0.006209:0.005798:0.007873:0.010845:0.017577:0.008811:0.006437:0.005545:0.008994:0.005798:0.009656:0.009039:0.011596:0.009131:0.006437:0.005547:0.008994:0.005798:0.009838:0.009085:0.007807:0.005798:0.008811:0.006437:0.005547:0.010843:0.011756:0.005798:0.005615:0.011756:0.004109
cancer genomes:@0.117647:0.188923:0.254747:0.188923:0.254747:0.168550:0.117647:0.168550:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.006140:0.009658:0.009039:0.011596:0.010843:0.017485:0.009039:0.007670
150,320:@0.254746:0.181307:0.293859:0.181307:0.293859:0.169429:0.254746:0.169429:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
, involving dozens to thousands of somatic SVs with varying size :@0.293857:0.188923:0.857042:0.188923:0.857042:0.168550:0.293857:0.168550:0.004497:0.006140:0.005615:0.011368:0.009633:0.010934:0.005182:0.009838:0.005615:0.011461:0.009861:0.006140:0.011322:0.010934:0.008834:0.009039:0.011619:0.007670:0.006140:0.006211:0.011048:0.006140:0.006620:0.011299:0.010820:0.011413:0.007944:0.009085:0.011596:0.011391:0.007670:0.006140:0.010843:0.006209:0.006140:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.006140:0.010112:0.015089:0.007670:0.006140:0.014723:0.005271:0.006620:0.011459:0.006140:0.009838:0.009085:0.008400:0.009724:0.005615:0.011459:0.009861:0.006140:0.007601:0.005615:0.008834:0.009039:0.004109
distribution and patterns . While some SVs represent simple deletions, others tend to :@0.117647:0.209502:0.857017:0.209502:0.857017:0.189129:0.117647:0.189129:0.011391:0.005615:0.007510:0.006437:0.007807:0.005547:0.010797:0.011071:0.006437:0.005547:0.010843:0.011756:0.005113:0.009085:0.011596:0.011391:0.005113:0.011368:0.008811:0.006163:0.006209:0.009039:0.007807:0.011619:0.007670:0.018251:0.004497:0.005113:0.020704:0.011459:0.005750:0.005182:0.009039:0.005113:0.007875:0.010843:0.017485:0.009039:0.005113:0.010112:0.015089:0.007670:0.005113:0.007442:0.009131:0.011071:0.007442:0.009039:0.007873:0.009039:0.011391:0.006437:0.005113:0.007601:0.005615:0.017280:0.011162:0.005182:0.009039:0.005113:0.011324:0.008946:0.005182:0.009131:0.006437:0.005547:0.010843:0.011621:0.007670:0.004497:0.005113:0.010820:0.006620:0.011299:0.009039:0.007624:0.007670:0.005113:0.006209:0.009039:0.011596:0.011391:0.005113:0.006209:0.011048:0.004109
150:@0.329395:0.201886:0.347640:0.201886:0.347640:0.190008:0.329395:0.190008:0.006082:0.006082:0.006082
be complex, involving multiple breakpoints across a relatively short genomic interval. :@0.117647:0.230080:0.857070:0.230080:0.857070:0.209707:0.117647:0.209707:0.011254:0.009039:0.006277:0.008994:0.010843:0.017280:0.011162:0.005182:0.009108:0.010089:0.004497:0.006277:0.005615:0.011365:0.009635:0.010934:0.005182:0.009838:0.005615:0.011459:0.009861:0.006277:0.017280:0.011550:0.004908:0.006437:0.005271:0.011162:0.005182:0.009039:0.006277:0.010818:0.007442:0.009291:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.007670:0.006277:0.009291:0.008994:0.007442:0.010957:0.007533:0.007670:0.006277:0.009291:0.006277:0.007442:0.008948:0.005433:0.008811:0.006437:0.005547:0.009633:0.008948:0.005182:0.009724:0.006277:0.007556:0.011299:0.010843:0.007967:0.006437:0.006277:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.006277:0.005615:0.011391:0.006209:0.009039:0.008400:0.009838:0.009405:0.004976:0.004497:0.004109
For example, chromothripsis is a form of complex SVs frequently observed in cancer :@0.117647:0.250659:0.856938:0.250659:0.856938:0.230286:0.117647:0.230286:0.010683:0.010843:0.007807:0.006323:0.009108:0.010089:0.009085:0.017280:0.011162:0.005182:0.008743:0.004497:0.006323:0.008768:0.011459:0.007442:0.010843:0.017485:0.010820:0.006620:0.011459:0.007807:0.005271:0.011185:0.007601:0.005615:0.007670:0.006323:0.005615:0.007670:0.006323:0.009291:0.006323:0.006026:0.010843:0.007807:0.017645:0.006323:0.010843:0.006209:0.006323:0.008994:0.010843:0.017280:0.011162:0.005182:0.009108:0.010089:0.006323:0.010112:0.015089:0.007670:0.006323:0.006414:0.007442:0.009108:0.010706:0.011345:0.009039:0.011391:0.006620:0.005182:0.009724:0.006323:0.010957:0.010934:0.007875:0.009039:0.008400:0.009633:0.009108:0.011391:0.006323:0.005615:0.011756:0.006323:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004109
genomes:@0.117647:0.271238:0.192975:0.271238:0.192975:0.250865:0.117647:0.250865:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.007670
154,156:@0.192976:0.263622:0.232088:0.263622:0.232088:0.251744:0.192976:0.251744:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
, resulting from aberrant chromosome segregation or telomere dysfunc-:@0.232087:0.271238:0.852941:0.271238:0.852941:0.250865:0.232087:0.250865:0.004497:0.006506:0.007442:0.009039:0.007510:0.011550:0.004908:0.006437:0.005615:0.011459:0.009861:0.006506:0.006414:0.007442:0.010843:0.017645:0.006506:0.009108:0.011251:0.009039:0.007807:0.007898:0.009085:0.011391:0.006437:0.006506:0.008765:0.011459:0.007442:0.010843:0.017485:0.010957:0.007875:0.010843:0.017485:0.009039:0.006506:0.007875:0.009039:0.009861:0.007439:0.009039:0.009861:0.008811:0.006437:0.005547:0.010843:0.011756:0.006506:0.010843:0.007807:0.006506:0.006209:0.008948:0.005182:0.010845:0.017483:0.009039:0.007444:0.009039:0.006506:0.011320:0.009724:0.007599:0.006369:0.011413:0.011596:0.009035:0.007533
tion:@0.117647:0.291816:0.152230:0.291816:0.152230:0.271444:0.117647:0.271444:0.006437:0.005547:0.010843:0.011756
321,322:@0.152230:0.284200:0.191342:0.284200:0.191342:0.272323:0.152230:0.272323:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
. Other types of complex SVs involve oncogene amplifications arising from :@0.191340:0.291816:0.856972:0.291816:0.856972:0.271444:0.191340:0.271444:0.004497:0.007647:0.016504:0.006620:0.011302:0.009039:0.007807:0.007647:0.006437:0.009724:0.011505:0.009039:0.007670:0.007647:0.010843:0.006209:0.007647:0.008994:0.010843:0.017280:0.011162:0.005182:0.009108:0.010089:0.007647:0.010112:0.015089:0.007670:0.007647:0.005615:0.011368:0.009633:0.010934:0.005182:0.009633:0.009039:0.007647:0.010843:0.011596:0.008994:0.011048:0.009656:0.009039:0.011596:0.009039:0.007647:0.009085:0.017280:0.011162:0.005250:0.005615:0.005684:0.005615:0.009108:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.007647:0.009085:0.007807:0.005615:0.007601:0.005615:0.011459:0.009861:0.007647:0.006414:0.007442:0.010843:0.017645:0.004109
breakage-fusion-bridge cycles:@0.117647:0.312395:0.375154:0.312395:0.375154:0.292022:0.117647:0.292022:0.010820:0.007442:0.009291:0.009405:0.010614:0.009199:0.009656:0.009039:0.007533:0.006366:0.011413:0.007601:0.005547:0.010843:0.011756:0.007533:0.010820:0.007807:0.005547:0.011391:0.009656:0.009039:0.009633:0.009382:0.009519:0.008765:0.005182:0.009039:0.007670
148,150,208:@0.375144:0.304779:0.435123:0.304779:0.435123:0.292902:0.375144:0.292902:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
. SVs  in  cancer genomes may  promote cancer :@0.435121:0.312395:0.857086:0.312395:0.857086:0.292022:0.435121:0.292022:0.004497:0.009633:0.010112:0.015089:0.007670:0.004109:0.005513:0.005615:0.011756:0.004109:0.005513:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.009633:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.007670:0.009633:0.017577:0.008925:0.009724:0.004109:0.005513:0.011071:0.007442:0.010843:0.017485:0.010820:0.006209:0.009039:0.009633:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004109
development through a variety of mechanisms, such as oncogene activation through :@0.117647:0.332974:0.857100:0.332974:0.857100:0.312601:0.117647:0.312601:0.011322:0.009336:0.009633:0.008948:0.005182:0.010820:0.011071:0.017485:0.009039:0.011391:0.006437:0.007053:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011459:0.007053:0.009291:0.007053:0.009838:0.009085:0.007807:0.005547:0.009131:0.006437:0.009724:0.007053:0.010843:0.006209:0.007053:0.017488:0.009106:0.008765:0.011391:0.009087:0.011756:0.005615:0.007599:0.017508:0.007670:0.004497:0.007053:0.007510:0.011345:0.008768:0.011459:0.007053:0.009291:0.007670:0.007053:0.010845:0.011596:0.008994:0.011048:0.009656:0.009039:0.011596:0.009039:0.007053:0.009291:0.009106:0.006437:0.005547:0.009838:0.008811:0.006437:0.005547:0.010843:0.011756:0.007053:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011459:0.004109
gene-fusions, disruption of tumor suppressor genes or by affecting gene regulation:@0.117647:0.353553:0.809417:0.353553:0.809417:0.333180:0.117647:0.333180:0.009656:0.009039:0.011596:0.009039:0.007533:0.006369:0.011413:0.007601:0.005547:0.010843:0.011619:0.007670:0.004497:0.004337:0.011391:0.005615:0.007601:0.007967:0.011071:0.011048:0.006437:0.005547:0.010843:0.011756:0.004337:0.010843:0.006209:0.004337:0.006163:0.011413:0.017488:0.010843:0.007807:0.004337:0.007510:0.011071:0.011048:0.011071:0.007442:0.009039:0.007533:0.007875:0.010843:0.007807:0.004337:0.009656:0.009039:0.011596:0.009039:0.007670:0.004337:0.010845:0.007807:0.004337:0.010843:0.009724:0.004337:0.009085:0.005969:0.005787:0.009108:0.009108:0.006437:0.005615:0.011459:0.009861:0.004337:0.009656:0.009039:0.011596:0.009039:0.004337:0.007442:0.009039:0.009861:0.011550:0.005433:0.008811:0.006437:0.005547:0.010843:0.011756
323,324:@0.809333:0.345937:0.848445:0.345937:0.848445:0.334059:0.809333:0.334059:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
. :@0.848444:0.353553:0.857050:0.353553:0.857050:0.333180:0.848444:0.333180:0.004497:0.004109
Oncogenic fusion genes resulting from somatic SVs form important targets for cancer :@0.117647:0.374131:0.857052:0.374131:0.857052:0.353758:0.117647:0.353758:0.016298:0.011596:0.008994:0.011048:0.009656:0.009039:0.011756:0.005547:0.008994:0.005570:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.005570:0.009656:0.009039:0.011596:0.009039:0.007670:0.005570:0.007442:0.009039:0.007510:0.011550:0.004908:0.006437:0.005615:0.011459:0.009861:0.005570:0.006414:0.007442:0.010843:0.017645:0.005570:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.005570:0.010112:0.015089:0.007670:0.005570:0.006026:0.010843:0.007807:0.017645:0.005570:0.005615:0.017280:0.011502:0.010845:0.007964:0.006551:0.009085:0.011391:0.006437:0.005570:0.006551:0.009085:0.007624:0.009656:0.009131:0.006437:0.007670:0.005570:0.006026:0.010843:0.007807:0.005570:0.009108:0.009085:0.011598:0.008994:0.009039:0.007807:0.004109
drugs, and somatic SVs may form neo-antigenic targets for immunotherapies , demon-:@0.117647:0.394710:0.852941:0.394710:0.852941:0.374337:0.117647:0.374337:0.011391:0.007967:0.011413:0.009724:0.007670:0.004497:0.003333:0.009085:0.011598:0.011391:0.003333:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.003333:0.010112:0.015089:0.007670:0.003333:0.017577:0.008925:0.009724:0.003333:0.006026:0.010843:0.007807:0.017645:0.003333:0.011596:0.009108:0.011048:0.007533:0.009085:0.011391:0.006437:0.005615:0.009656:0.009039:0.011756:0.005545:0.008994:0.003333:0.006551:0.009085:0.007624:0.009656:0.009131:0.006437:0.007670:0.003333:0.006026:0.010843:0.007807:0.003333:0.005615:0.017645:0.017280:0.011413:0.011596:0.010820:0.006620:0.011299:0.009039:0.007898:0.008811:0.011071:0.005547:0.009039:0.007670:0.018257:0.004497:0.003333:0.011322:0.009039:0.017485:0.010843:0.011758:0.007533
325:@0.758887:0.387094:0.777132:0.387094:0.777132:0.375216:0.758887:0.375216:0.006082:0.006082:0.006082
strating the relevance of accurate somatic SV detection for personalized cancer treat-:@0.117647:0.415289:0.852941:0.415289:0.852941:0.394916:0.117647:0.394916:0.007510:0.006437:0.007898:0.008811:0.006437:0.005615:0.011459:0.009861:0.006528:0.006620:0.011299:0.009039:0.006528:0.007442:0.008948:0.005182:0.009336:0.009838:0.009085:0.011596:0.008994:0.009039:0.006528:0.010845:0.006209:0.006528:0.009291:0.008994:0.009108:0.011413:0.007898:0.008811:0.006209:0.009039:0.006528:0.007875:0.010843:0.017577:0.008811:0.006437:0.005547:0.008994:0.006528:0.010112:0.015089:0.006528:0.011324:0.009128:0.006211:0.009106:0.009108:0.006437:0.005547:0.010843:0.011756:0.006528:0.006026:0.010843:0.007807:0.006528:0.011505:0.009039:0.007624:0.007873:0.010845:0.011687:0.009405:0.005250:0.005615:0.008834:0.009108:0.011391:0.006528:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.006528:0.006437:0.007442:0.009291:0.008811:0.006478:0.007533
ment:@0.117647:0.435867:0.161999:0.435867:0.161999:0.415494:0.117647:0.415494:0.017485:0.009039:0.011391:0.006437
158,324:@0.162000:0.428251:0.201112:0.428251:0.201112:0.416374:0.162000:0.416374:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
.:@0.201110:0.435867:0.205607:0.435867:0.205607:0.415494:0.201110:0.415494:0.004497
While classical karyotyping and FISH analyses have been instrumental in systematic :@0.117647:0.477025:0.857116:0.477025:0.857116:0.456652:0.117647:0.456652:0.020704:0.011459:0.005752:0.005182:0.009039:0.007099:0.008765:0.005433:0.009291:0.007533:0.007601:0.005547:0.009108:0.009405:0.005250:0.007099:0.010614:0.009085:0.008400:0.009519:0.010820:0.006437:0.009724:0.011071:0.005615:0.011459:0.009861:0.007099:0.009085:0.011596:0.011391:0.007099:0.011276:0.007259:0.009770:0.016846:0.007099:0.009085:0.011687:0.009405:0.005182:0.009724:0.007875:0.009039:0.007670:0.007099:0.011391:0.008925:0.009633:0.009039:0.007099:0.011254:0.009106:0.009039:0.011756:0.007099:0.005615:0.011619:0.007510:0.006437:0.007964:0.011413:0.017488:0.009039:0.011391:0.006549:0.009405:0.005250:0.007099:0.005615:0.011756:0.007099:0.007761:0.009724:0.007510:0.006209:0.009039:0.017577:0.008811:0.006437:0.005547:0.008994:0.004109
copy number analyses in tumor samples:@0.117647:0.497603:0.462589:0.497603:0.462589:0.477231:0.117647:0.477231:0.008994:0.010820:0.011094:0.009724:0.005579:0.011393:0.011413:0.017394:0.011251:0.009039:0.007807:0.005581:0.009085:0.011687:0.009405:0.005182:0.009724:0.007875:0.009039:0.007670:0.005579:0.005615:0.011756:0.005581:0.006163:0.011413:0.017485:0.010843:0.007807:0.005581:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670
158,324:@0.462589:0.489987:0.501702:0.489987:0.501702:0.478110:0.462589:0.478110:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
, these technologies provide limited reso-:@0.501700:0.497603:0.852941:0.497603:0.852941:0.477231:0.501700:0.477231:0.004497:0.005581:0.006620:0.011299:0.009039:0.007873:0.009039:0.005581:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.005581:0.011071:0.007442:0.010866:0.009838:0.005547:0.011322:0.009039:0.005579:0.005250:0.005615:0.017645:0.005273:0.006209:0.009108:0.011391:0.005579:0.007442:0.009039:0.007875:0.011049:0.007533
lution or do not allow for comprehensive genome-wide analysis and are thus unable to :@0.117647:0.518182:0.857059:0.518182:0.857059:0.497809:0.117647:0.497809:0.004908:0.011071:0.006437:0.005547:0.010843:0.011756:0.005033:0.010843:0.007807:0.005045:0.011322:0.011048:0.005033:0.011596:0.010820:0.006437:0.005033:0.009405:0.005387:0.005182:0.010866:0.014723:0.005033:0.006026:0.010843:0.007807:0.005033:0.008994:0.010843:0.017280:0.011071:0.007442:0.008950:0.011299:0.009039:0.011619:0.007601:0.005547:0.009633:0.009039:0.005033:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.007533:0.014723:0.005547:0.011322:0.009039:0.005033:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.005033:0.009085:0.011598:0.011391:0.005033:0.009085:0.007442:0.009039:0.005033:0.006620:0.011094:0.011413:0.007670:0.005033:0.011413:0.011690:0.009108:0.010911:0.005182:0.009039:0.005033:0.006209:0.011048:0.004109
resolve the complete spectrum of SV events. Most of our knowledge on genome-wide :@0.117647:0.538761:0.857118:0.538761:0.857118:0.518388:0.117647:0.518388:0.007442:0.009039:0.007875:0.010934:0.005182:0.009633:0.009039:0.005730:0.006617:0.011302:0.009039:0.005730:0.008994:0.010843:0.017280:0.011162:0.005182:0.009131:0.006209:0.009039:0.005730:0.007510:0.011502:0.009108:0.009108:0.006437:0.007967:0.011413:0.017645:0.005730:0.010843:0.006209:0.005730:0.010112:0.015089:0.005730:0.009334:0.009633:0.009039:0.011391:0.006437:0.007670:0.004497:0.005730:0.018969:0.010957:0.007510:0.006437:0.005730:0.010843:0.006209:0.005730:0.010820:0.011413:0.007807:0.005730:0.010706:0.011596:0.010866:0.014792:0.005182:0.009108:0.011391:0.009656:0.009039:0.005730:0.010845:0.011756:0.005730:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.007533:0.014723:0.005547:0.011322:0.009039:0.004109
high-resolution SVs in cancer genomes stems from the analysis of short-read whole ge-:@0.117647:0.559340:0.852941:0.559340:0.852941:0.538967:0.117647:0.538967:0.011459:0.005615:0.009930:0.011459:0.007533:0.007442:0.009039:0.007873:0.010934:0.004908:0.011071:0.006437:0.005547:0.010843:0.011756:0.004634:0.010112:0.015089:0.007670:0.004620:0.005615:0.011756:0.004622:0.009108:0.009085:0.011598:0.008994:0.009039:0.007807:0.004620:0.009656:0.009039:0.011596:0.010845:0.017485:0.009039:0.007670:0.004622:0.007510:0.006209:0.009039:0.017508:0.007670:0.004622:0.006414:0.007442:0.010843:0.017645:0.004622:0.006620:0.011299:0.009039:0.004622:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.004622:0.010843:0.006209:0.004622:0.007556:0.011299:0.010843:0.007967:0.006437:0.007533:0.007442:0.009291:0.009291:0.011391:0.004622:0.014789:0.011302:0.010934:0.005182:0.009039:0.004622:0.009656:0.009028:0.007533
nome sequencing, which is currently the only scalable and cost-efficient technology for :@0.117647:0.579918:0.856988:0.579918:0.856988:0.559545:0.117647:0.559545:0.011596:0.010843:0.017485:0.009039:0.004771:0.007875:0.009108:0.010703:0.011347:0.009039:0.011596:0.008994:0.005615:0.011459:0.009679:0.004497:0.004771:0.014792:0.011459:0.005547:0.008765:0.011459:0.004771:0.005615:0.007670:0.004771:0.009108:0.011413:0.007807:0.007442:0.009039:0.011391:0.006620:0.005182:0.009724:0.004771:0.006620:0.011299:0.009039:0.004771:0.010845:0.011868:0.005184:0.009724:0.004771:0.007875:0.009108:0.009405:0.005433:0.009108:0.010911:0.005182:0.009039:0.004771:0.009085:0.011598:0.011391:0.004771:0.008994:0.010957:0.007510:0.006437:0.007533:0.009039:0.005692:0.005692:0.005623:0.008994:0.005547:0.009039:0.011391:0.006437:0.004771:0.006209:0.009106:0.008768:0.011459:0.011598:0.010934:0.005182:0.011048:0.010544:0.009724:0.004771:0.006026:0.010843:0.007807:0.004109
high-resolution genome-wide cancer genome analysis:@0.117647:0.600497:0.570460:0.600497:0.570460:0.580124:0.117647:0.580124:0.011459:0.005615:0.009930:0.011459:0.007533:0.007442:0.009039:0.007873:0.010934:0.004908:0.011071:0.006437:0.005547:0.010843:0.011756:0.003972:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.007533:0.014723:0.005547:0.011322:0.009039:0.003972:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.003972:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.003972:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670
146,150:@0.570447:0.592881:0.609559:0.592881:0.609559:0.581004:0.570447:0.581004:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
. Although short reads are ef-:@0.609558:0.600497:0.852941:0.600497:0.852941:0.580124:0.609558:0.580124:0.004497:0.003972:0.015066:0.004908:0.006620:0.011299:0.010820:0.011413:0.009930:0.011459:0.003972:0.007556:0.011299:0.010843:0.007967:0.006437:0.003972:0.007442:0.009291:0.009291:0.011391:0.007670:0.003972:0.009085:0.007442:0.009039:0.003972:0.009039:0.006190:0.007533
fective for detection of simple SV breakpoints in non-repetitive regions of the genome, :@0.117647:0.621076:0.856981:0.621076:0.856981:0.600703:0.117647:0.600703:0.006026:0.009108:0.009108:0.006437:0.005547:0.009633:0.009039:0.005068:0.006026:0.010843:0.007807:0.005068:0.011322:0.009128:0.006211:0.009106:0.009108:0.006437:0.005547:0.010843:0.011756:0.005068:0.010843:0.006209:0.005068:0.007601:0.005615:0.017280:0.011162:0.005182:0.009039:0.005068:0.010112:0.015089:0.005068:0.010820:0.007442:0.009291:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.007670:0.005068:0.005615:0.011756:0.005068:0.011596:0.010845:0.011756:0.007533:0.007439:0.009131:0.011505:0.009131:0.006437:0.005273:0.006437:0.005547:0.009633:0.009039:0.005068:0.007442:0.009039:0.009861:0.005547:0.010843:0.011619:0.007670:0.005068:0.010843:0.006209:0.005068:0.006620:0.011299:0.009039:0.005068:0.009656:0.009039:0.011596:0.010843:0.017485:0.008743:0.004497:0.004109
the interrogation of complexly rearranged regions or the detection of SV breakpoints :@0.117647:0.641654:0.857048:0.641654:0.857048:0.621281:0.117647:0.621281:0.006620:0.011299:0.009039:0.006334:0.005615:0.011388:0.006209:0.009039:0.007807:0.007442:0.011048:0.009861:0.008811:0.006437:0.005547:0.010843:0.011756:0.006334:0.010843:0.006209:0.006332:0.008994:0.010843:0.017280:0.011162:0.005182:0.009108:0.010089:0.005182:0.009724:0.006332:0.007442:0.009291:0.009085:0.007807:0.007898:0.009085:0.011461:0.009656:0.009108:0.011391:0.006332:0.007442:0.009039:0.009861:0.005547:0.010843:0.011619:0.007670:0.006332:0.010843:0.007807:0.006334:0.006620:0.011299:0.009039:0.006332:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.006334:0.010843:0.006209:0.006332:0.010112:0.015089:0.006332:0.010820:0.007442:0.009291:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.007670:0.004109
in low complexity genomic regions may require other sequencing techniques or target-:@0.117647:0.662233:0.852941:0.662233:0.852941:0.641860:0.117647:0.641860:0.005615:0.011756:0.004839:0.005182:0.010866:0.014723:0.004839:0.008994:0.010843:0.017280:0.011160:0.005184:0.009106:0.010089:0.005273:0.006437:0.009724:0.004839:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.004839:0.007442:0.009039:0.009861:0.005547:0.010843:0.011619:0.007670:0.004839:0.017577:0.008925:0.009724:0.004839:0.007442:0.009108:0.010703:0.011413:0.005615:0.007442:0.009039:0.004839:0.010820:0.006620:0.011299:0.009039:0.007807:0.004839:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.004839:0.006209:0.009108:0.008765:0.011459:0.011756:0.005547:0.010703:0.011347:0.009039:0.007670:0.004839:0.010843:0.007807:0.004839:0.006551:0.009085:0.007624:0.009656:0.009131:0.006485:0.007533
ed approaches . For example, long-insert mate-pair sequencing has proven a valuable :@0.117647:0.682812:0.857057:0.682812:0.857057:0.662439:0.117647:0.662439:0.009108:0.011391:0.005250:0.008811:0.011046:0.011073:0.007442:0.011137:0.009291:0.008768:0.011299:0.009039:0.007670:0.018244:0.004497:0.005250:0.010683:0.010843:0.007807:0.005250:0.009108:0.010089:0.009085:0.017280:0.011162:0.005182:0.008743:0.004497:0.005250:0.005182:0.010843:0.011459:0.009861:0.007533:0.005615:0.011619:0.007875:0.009039:0.007967:0.006437:0.005250:0.017577:0.008811:0.006211:0.009039:0.007533:0.011368:0.009085:0.005615:0.007807:0.005250:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.005250:0.011391:0.009291:0.007670:0.005250:0.011071:0.007442:0.010866:0.009633:0.009039:0.011756:0.005250:0.009291:0.005250:0.009838:0.009405:0.004905:0.011596:0.009108:0.010911:0.005182:0.009039:0.004109
326:@0.238970:0.675196:0.257216:0.675196:0.257216:0.663318:0.238970:0.663318:0.006082:0.006082:0.006082
strategy for genome-wide mapping of somatic SVs:@0.117647:0.703390:0.548089:0.703390:0.548089:0.683018:0.117647:0.683018:0.007510:0.006437:0.007898:0.008811:0.006209:0.009039:0.010546:0.009724:0.005387:0.006024:0.010843:0.007807:0.005387:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.007533:0.014723:0.005547:0.011322:0.009039:0.005387:0.017577:0.008813:0.011048:0.011069:0.005615:0.011459:0.009861:0.005387:0.010843:0.006209:0.005387:0.007873:0.010843:0.017579:0.008811:0.006437:0.005547:0.008994:0.005387:0.010112:0.015089:0.007670
155,327:@0.548139:0.695774:0.587252:0.695774:0.587252:0.683897:0.548139:0.683897:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
 and single-cell template strand :@0.587250:0.703390:0.857017:0.703390:0.857017:0.683018:0.587250:0.683018:0.005387:0.009085:0.011596:0.011391:0.005387:0.007601:0.005615:0.011459:0.009930:0.005182:0.009039:0.007533:0.008994:0.008948:0.005387:0.005250:0.005387:0.006209:0.009039:0.017280:0.011162:0.005430:0.008811:0.006211:0.009039:0.005387:0.007510:0.006437:0.007898:0.009085:0.011596:0.011391:0.004109
sequencing enables the detection of copy number variants and copy neutral structural :@0.117647:0.723969:0.857007:0.723969:0.857007:0.703596:0.117647:0.703596:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.005593:0.009039:0.011687:0.009108:0.010911:0.005182:0.009039:0.007670:0.005593:0.006620:0.011302:0.009039:0.005593:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.005593:0.010843:0.006209:0.005593:0.008994:0.010822:0.011092:0.009724:0.005593:0.011391:0.011413:0.017394:0.011254:0.009039:0.007807:0.005593:0.009838:0.009085:0.007807:0.005798:0.009085:0.011391:0.006437:0.007670:0.005593:0.009085:0.011596:0.011391:0.005593:0.008994:0.010820:0.011092:0.009724:0.005593:0.011598:0.009128:0.011071:0.006437:0.007898:0.009405:0.005250:0.005593:0.007510:0.006437:0.007967:0.011345:0.009108:0.006163:0.011413:0.007898:0.009405:0.005250:0.004109
variants . Furthermore, long-read sequencing methods, such as Pacific Biosciences and :@0.117647:0.744548:0.857079:0.744548:0.857079:0.724175:0.117647:0.724175:0.009838:0.009085:0.007807:0.005798:0.009085:0.011391:0.006437:0.007670:0.018245:0.004497:0.003652:0.010726:0.011413:0.007967:0.006620:0.011299:0.009039:0.007807:0.017485:0.010843:0.007444:0.008743:0.004497:0.003652:0.005182:0.010843:0.011459:0.009861:0.007533:0.007442:0.009291:0.009291:0.011391:0.003652:0.007873:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.003652:0.017485:0.009131:0.006620:0.011299:0.011276:0.011391:0.007670:0.004497:0.003652:0.007510:0.011347:0.008763:0.011459:0.003652:0.009291:0.007670:0.003652:0.011413:0.009291:0.008994:0.005615:0.005684:0.005613:0.008994:0.003652:0.012486:0.005547:0.010957:0.007875:0.008994:0.005547:0.009039:0.011596:0.008994:0.009039:0.007670:0.003652:0.009087:0.011596:0.011391:0.004109
328:@0.184758:0.736932:0.203003:0.736932:0.203003:0.725054:0.184758:0.725054:0.006082:0.006082:0.006082
Oxford Nanopore and synthetic long-read approaches, such as linked-read technology :@0.117647:0.765127:0.857050:0.765127:0.857050:0.744754:0.117647:0.744754:0.016298:0.010089:0.006026:0.010843:0.007442:0.011391:0.005214:0.015545:0.009085:0.011598:0.010820:0.011502:0.010843:0.007442:0.009039:0.005216:0.009085:0.011596:0.011391:0.005216:0.007759:0.009724:0.011391:0.006620:0.011302:0.009128:0.006437:0.005547:0.008994:0.005216:0.005182:0.010843:0.011459:0.009861:0.007533:0.007442:0.009291:0.009291:0.011391:0.005214:0.008811:0.011048:0.011071:0.007442:0.011139:0.009291:0.008765:0.011299:0.009039:0.007670:0.004497:0.005214:0.007512:0.011345:0.008765:0.011459:0.005214:0.009291:0.007670:0.005214:0.005250:0.005615:0.011870:0.010272:0.009108:0.011391:0.007533:0.007442:0.009291:0.009291:0.011391:0.005214:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.010546:0.009724:0.004109
by 10x genomics, provide a promising alternative for the detection of SVs. Initial studies :@0.117647:0.785705:0.856959:0.785705:0.856959:0.765332:0.117647:0.765332:0.010843:0.009724:0.004086:0.010432:0.010432:0.010089:0.004086:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.007670:0.004497:0.004086:0.011071:0.007442:0.010866:0.009838:0.005547:0.011322:0.009039:0.004086:0.009291:0.004086:0.011071:0.007442:0.010843:0.017645:0.005615:0.007601:0.005615:0.011459:0.009861:0.004086:0.009405:0.004908:0.006209:0.009039:0.007807:0.011687:0.008811:0.006437:0.005547:0.009633:0.009039:0.004086:0.006024:0.010845:0.007807:0.004086:0.006620:0.011299:0.009039:0.004086:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.004086:0.010843:0.006209:0.004086:0.010112:0.015089:0.007670:0.004497:0.004086:0.006894:0.011756:0.005273:0.006437:0.005798:0.009402:0.005250:0.004086:0.007510:0.006163:0.011345:0.011391:0.005547:0.009039:0.007670:0.004109
have shown that long-read single-molecule sequencing can greatly improve detection of :@0.117647:0.806284:0.857004:0.806284:0.857004:0.785911:0.117647:0.785911:0.011391:0.008925:0.009633:0.009039:0.004063:0.007556:0.011299:0.010866:0.014723:0.011756:0.004063:0.006620:0.011391:0.008811:0.006437:0.004063:0.005182:0.010843:0.011459:0.009861:0.007533:0.007442:0.009291:0.009291:0.011391:0.004063:0.007601:0.005615:0.011459:0.009930:0.005182:0.009039:0.007533:0.017485:0.010934:0.005182:0.009108:0.009108:0.011550:0.005182:0.009039:0.004063:0.007873:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.004063:0.009108:0.009085:0.011756:0.004063:0.009861:0.007442:0.009291:0.008811:0.006620:0.005182:0.009724:0.004063:0.005615:0.017280:0.011071:0.007442:0.010866:0.009633:0.009039:0.004063:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.004063:0.010843:0.006209:0.004109
germline SVs:@0.117647:0.826863:0.230902:0.826863:0.230902:0.806490:0.117647:0.806490:0.009656:0.009039:0.007807:0.017759:0.005250:0.005615:0.011596:0.009039:0.004622:0.010112:0.015089:0.007670
196,199,200,204:@0.230902:0.819247:0.311748:0.819247:0.311748:0.807369:0.230902:0.807369:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
. Similarly, recent work has demonstrated the advantage of long-:@0.311745:0.826863:0.852970:0.826863:0.852970:0.806490:0.311745:0.806490:0.004497:0.004622:0.010112:0.005615:0.017645:0.005752:0.005433:0.009085:0.007601:0.005182:0.007989:0.004497:0.004622:0.007442:0.009108:0.008994:0.009039:0.011391:0.006437:0.004634:0.014518:0.010843:0.007601:0.010523:0.004622:0.011391:0.009291:0.007670:0.004634:0.011322:0.009039:0.017485:0.010843:0.011619:0.007510:0.006437:0.007898:0.008811:0.006209:0.009108:0.011391:0.004622:0.006620:0.011299:0.009039:0.004634:0.009291:0.011322:0.009838:0.009085:0.011391:0.006551:0.009199:0.009656:0.009039:0.004622:0.010843:0.006209:0.004622:0.005182:0.010845:0.011459:0.009861:0.007533
range sequence information for identification of SVs in cancer genomes, such as cancer :@0.117647:0.847441:0.857052:0.847441:0.857052:0.827068:0.117647:0.827068:0.007898:0.009085:0.011459:0.009656:0.009039:0.004600:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.009039:0.004600:0.005615:0.011756:0.006026:0.010843:0.007807:0.017577:0.008811:0.006437:0.005547:0.010843:0.011756:0.004600:0.006024:0.010845:0.007807:0.004597:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.004600:0.010843:0.006209:0.004600:0.010112:0.015089:0.007670:0.004600:0.005615:0.011756:0.004597:0.009108:0.009087:0.011596:0.008994:0.009039:0.007807:0.004597:0.009656:0.009039:0.011598:0.010843:0.017485:0.009039:0.007670:0.004497:0.004600:0.007512:0.011345:0.008765:0.011459:0.004600:0.009291:0.007670:0.004597:0.009108:0.009085:0.011598:0.008994:0.009039:0.007807:0.004109
gene amplifications and gene fusion events:@0.117647:0.868020:0.475685:0.868020:0.475685:0.847647:0.117647:0.847647:0.009656:0.009039:0.011596:0.009039:0.004109:0.009085:0.017280:0.011162:0.005250:0.005615:0.005684:0.005615:0.009108:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004109:0.009085:0.011596:0.011391:0.004109:0.009656:0.009039:0.011596:0.009039:0.004109:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.004109:0.009334:0.009635:0.009039:0.011391:0.006437:0.007670
179,208,211,329:@0.475684:0.860404:0.556530:0.860404:0.556530:0.848527:0.475684:0.848527:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
. :@0.556527:0.868020:0.565133:0.868020:0.565133:0.847647:0.556527:0.847647:0.004497:0.004109
A major limitation of studies on cancer SVs is the lack of a comprehensive ground truth :@0.117647:0.909178:0.857007:0.909178:0.857007:0.888805:0.117647:0.888805:0.014929:0.004291:0.017577:0.008811:0.005341:0.010843:0.007807:0.004291:0.005250:0.005615:0.017645:0.005271:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.004291:0.010843:0.006209:0.004291:0.007510:0.006163:0.011345:0.011391:0.005547:0.009039:0.007670:0.004291:0.010843:0.011756:0.004291:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004291:0.010112:0.015089:0.007670:0.004291:0.005615:0.007670:0.004291:0.006620:0.011299:0.009039:0.004291:0.005433:0.009291:0.008765:0.010523:0.004291:0.010843:0.006209:0.004291:0.009291:0.004291:0.008994:0.010843:0.017280:0.011071:0.007442:0.008948:0.011299:0.009039:0.011619:0.007601:0.005547:0.009633:0.009039:0.004291:0.009861:0.007442:0.010820:0.011413:0.011598:0.011391:0.004291:0.006437:0.007967:0.011071:0.006620:0.011459:0.004109